Verona Pharma (VRP)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

Trade now with BarclaysStockbrokers Trade now with Barclays Sponsored by Barclays Stockbrokers

108.00p
   
  • Change Today:
    -2.50p
  • 52 Week High: 168.75
  • 52 Week Low: 106.00
  • Currency: UK Pounds
  • Shares Issued: 105.02m
  • Volume: 17,647
  • Market Cap: 113.42m
  • RiskGrade: 173

Verona Pharma Overview

Verona Pharma is developing first in class drugs to treat respiratory disease such as COPD asthma and chronic severe cough

1 Day Chart

6 Month Chart

Financials

Latest F'cast
Div Yield 0.0% 0.0%
Div Cover n/a n/a
Op Mrgn n/a n/a
ROCE n/a  
Latest F'cast
P/E n/a n/a
PEG n/a n/a
Pr/Revenue n/a n/a
Pr/Book 3.3  
Latest F'cast
Revenue n/a n/a
PBT n/a n/a
EPS n/a n/a
DPS n/a n/a

Verona Pharma Fundamentals

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-12 n/a (2.57) (39.35)p n/a n/a n/a n/a 0.0%
31-Dec-13 n/a (2.81) (35.51)p n/a n/a n/a n/a 0.0%
31-Dec-14 n/a (3.76) (16.00)p n/a n/a n/a n/a 0.0%
31-Dec-15 n/a (9.00) (1,855.00)p n/a n/a n/a n/a 0.0%
31-Dec-16 n/a (5.97) (749.00)p n/a n/a n/a n/a 0.0%

a. Based on UK GAAP presentation of accounts - includes discontinued activities

Verona Pharma Forecasts

Year Ending Revenue (m) Pre-tax (m) EPS P/E PEG EPS Grth. Div Yield
31-Dec-17 n/a (24.77) (24.26)p n/a n/a n/a n/a 0.0%
31-Dec-18 n/a (30.17) (25.55)p n/a n/a n/a n/a 0.0%

Copyright © 2017 FactSet Research Systems Inc. All rights reserved.

Verona Pharma Company Announcements

Verona Pharma plc : Block listing Interim Review 30-Nov-2017 18:52 GlobeNewswire EU
Verona Pharma plc : PDMR Dealing 30-Nov-2017 13:56 GlobeNewswire EU
Verona Pharma plc Operational Update and Financi... 07-Nov-2017 07:00 GlobeNewswire EU

Latest Verona Pharma Director Deals

Traded Action Notifier PriceAmountValue
29-Nov-17 Buy David Ebsworth 106.85p 10,000 10,685.00

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

Note 3: Above ratios are on a 'per annum' basis, adjusted for corporate actions and based on the fundamentals of the primary listed security.

Note 4: Under IFRS, all figures are based on 'Continuing' operations unless otherwise stated.

Note 5: In the case of dual listed securities, broker recommendations and forecasts relate to the primary listing.

Note 6: Forecast figures based on normalised accounts.

 

Verona Pharma Market Data

Currency UK Pounds
Share Price 108.00p
Change Today -2.50p
% Change -2.26 %
52 Week High 168.75
52 Week Low 106.00
Volume 17,647
Shares Issued 105.02m
Market Cap 113.42m
RiskGrade 173

Verona Pharma Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
38.45% below the market average38.45% below the market average38.45% below the market average38.45% below the market average38.45% below the market average
6.45% above the sector average6.45% above the sector average6.45% above the sector average6.45% above the sector average6.45% above the sector average
Price Trend
72.86% below the market average72.86% below the market average72.86% below the market average72.86% below the market average72.86% below the market average
41.54% below the sector average41.54% below the sector average41.54% below the sector average41.54% below the sector average41.54% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 5
Buy 0
Neutral 0
Sell 0
Strong Sell 0
Total 5
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Verona Pharma Dividends

No dividends found

Trades for 15-Dec-2017

Time Volume / Share Price
16:47 5,000 @ 110.00p
15:12 6,949 @ 106.00p
14:38 2,000 @ 107.00p
09:51 400 @ 109.88p
09:13 152 @ 109.50p

Verona Pharma Key Personnel

CEO Sven Jan-Anders Karlsson
CFO Piers Morgan

Top of Page